Status:
RECRUITING
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging
Lead Sponsor:
Poitiers University Hospital
Conditions:
Development of the Virtual Biopsy
Tumor Grade
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision....
Eligibility Criteria
Inclusion
- Age≥ 18 years,
- Patient with suspected glioma with prior imaging
- Subject free, with legal protection guardianship or curatorship;
- Enrollment in the French Social Security system;
- Informed consent signed by the patient
Exclusion
- Any contraindication to an MRI examination
- Legal protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons residing in a health or social establishment, adults under legal protection and finally patients in emergency situations
- Pregnant or lactating women, women of childbearing age who do not have effective contraception
Key Trial Info
Start Date :
February 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04313140
Start Date
February 22 2021
End Date
June 1 2026
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU De Poitiers
Poitiers, France